SciSparc (SPRC) Change in Account Payables (2016 - 2018)
SciSparc (SPRC) posted Change in Account Payables of -$151000.0 for Q4 2018, down 170.23% sequentially from $215000.0 in Q3 2018, and down 133.19% YoY from $455000.0 in Q4 2017.
SciSparc (SPRC) Change in Account Payables (2016 - 2018) Analysis & Trends
SciSparc has reported Change in Account Payables for 3 years, with the latest figure at -$151000.0 in Q4 2018.
- Quarterly Change in Account Payables fell 133.19% year-over-year to -$151000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $177000.0 (down 49.28% YoY) and the FY2025 annual result came in at -$164000.0, down 756.0% from the prior year.
- Change in Account Payables fell to -$151000.0 in Q4 2018 per SPRC's latest filing, from $215000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $455000.0 in Q4 2017 and troughed at -$406000.0 in Q2 2017.
- A 3-year average of $65545.5 and a median of $2000.0 in 2016 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2017 and 2018: Change in Account Payables plunged 20400.0% in 2017, then soared 4400.0% in 2018.
- Over 3 years, Change in Account Payables stood at -$60000.0 in 2016, then surged by 858.33% to $455000.0 in 2017, then sank by 133.19% to -$151000.0 in 2018.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$151000.0, $215000.0, and -$101000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -151,000.00 |
| Dec 31, 2018 | -151,000.00 |
| Sep 30, 2018 | 215,000.00 |
| Sep 30, 2018 | 215,000.00 |
| Jun 30, 2018 | -101,000.00 |
| Jun 30, 2018 | -101,000.00 |
| Mar 31, 2018 | 214,000.00 |
| Mar 31, 2018 | 214,000.00 |
| Dec 31, 2017 | 455,000.00 |
| Dec 31, 2017 | 455,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Jun 30, 2017 | -406,000.00 |
| Jun 30, 2017 | -406,000.00 |
| Mar 31, 2017 | 305,000.00 |
| Mar 31, 2017 | 305,000.00 |
| Dec 31, 2016 | -60,000.00 |
| Dec 31, 2016 | -60,000.00 |
| Sep 30, 2016 | 253,000.00 |
| Sep 30, 2016 | 253,000.00 |